NCT00002996View on ClinicalTrials.gov

Flecainide in Treating Patients With Chronic Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 4, 1998

Primary Completion Date

April 30, 2006

Conditions
Pain
Interventions
DRUG

flecainide acetate

Trial Locations (6)

55905

Mayo Clinic Cancer Center, Rochester

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

49007-3731

CCOP - Kalamazoo, Kalamazoo

53792-0001

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00002996 - Flecainide in Treating Patients With Chronic Neuropathic Pain | Biotech Hunter | Biotech Hunter